Progenitor-like exhausted SPRY1+CD8+ T cells potentiate responsiveness to neoadjuvant PD-1 blockade in esophageal squamous cell carcinoma DOI Creative Commons
Zhichao Liu, Yaru Zhang, Ning Ma

et al.

Cancer Cell, Journal Year: 2023, Volume and Issue: 41(11), P. 1852 - 1870.e9

Published: Oct. 12, 2023

Neoadjuvant immune checkpoint blockade (ICB) demonstrates promise in operable esophageal squamous cell carcinoma (ESCC), but lacks available efficacy biomarkers. Here, we perform single-cell RNA-sequencing of tumors from patients with ESCC undergoing neoadjuvant ICB, revealing a subset exhausted CD8+ T cells expressing SPRY1 (CD8+ Tex-SPRY1) that displays progenitor (Tpex) phenotype and correlates complete response to ICB. We validate Tex-SPRY1 as an ICB-specific predictor improved survival using independent ICB-/non-ICB cohorts demonstrate expression enforces Tpex enhances ICB efficacy. Additionally, contribute proinflammatory macrophages functional state B cells, which thereby promotes antitumor immunity by enhancing effector functions. Overall, our findings unravel progenitor-like cells' role effective responses for inform mechanistic biomarkers future individualized immunotherapy.

Language: Английский

Kidney fibrosis: from mechanisms to therapeutic medicines DOI Creative Commons

Rongshuang Huang,

Ping Fu, Liang Ma

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2023, Volume and Issue: 8(1)

Published: March 17, 2023

Abstract Chronic kidney disease (CKD) is estimated to affect 10–14% of global population. Kidney fibrosis, characterized by excessive extracellular matrix deposition leading scarring, a hallmark manifestation in different progressive CKD; However, at present no antifibrotic therapies against CKD exist. fibrosis identified tubule atrophy, interstitial chronic inflammation and fibrogenesis, glomerulosclerosis, vascular rarefaction. Fibrotic niche, where organ initiates, complex interplay between injured parenchyma (like tubular cells) multiple non-parenchymal cell lineages (immune mesenchymal located spatially within scarring areas. Although the mechanisms are complicated due kinds cells involved, with help single-cell technology, many key questions have been explored, such as what kind renal tubules profibrotic, myofibroblasts originate, which immune how communicate each other. In addition, genetics epigenetics deeper that regulate fibrosis. And reversible nature epigenetic changes including DNA methylation, RNA interference, chromatin remodeling, gives an opportunity stop or reverse therapeutic strategies. More marketed (e.g., RAS blockage, SGLT2 inhibitors) developed delay progression recent years. Furthermore, better understanding also favored discover biomarkers fibrotic injury. review, we update advances mechanism summarize novel treatment for CKD.

Language: Английский

Citations

267

Dynamics and specificities of T cells in cancer immunotherapy DOI
Giacomo Oliveira, Catherine J. Wu

Nature reviews. Cancer, Journal Year: 2023, Volume and Issue: 23(5), P. 295 - 316

Published: April 12, 2023

Language: Английский

Citations

240

Tumor Microenvironment in Pancreatic Cancer Pathogenesis and Therapeutic Resistance DOI Creative Commons
Mara H. Sherman, Gregory L. Beatty

Annual Review of Pathology Mechanisms of Disease, Journal Year: 2022, Volume and Issue: 18(1), P. 123 - 148

Published: Sept. 21, 2022

Pancreatic ductal adenocarcinoma (PDAC) features a prominent stromal microenvironment with remarkable cellular and spatial heterogeneity that meaningfully impacts disease biology treatment resistance. Recent advances in tissue imaging capabilities, single-cell analytics, modeling have shed light on organizing principles shape the complexity of PDAC tumors. These insights into functional dependencies coordinate cancer cell relationships exist between cells extracellular matrix components present tumors are expected to unveil therapeutic vulnerabilities. We review recent field discuss current understandings mechanisms by which tumor shapes pathogenesis therapy

Language: Английский

Citations

206

Spatial profiling technologies illuminate the tumor microenvironment DOI Creative Commons
Ofer Elhanani, Raz Ben-Uri, Leeat Keren

et al.

Cancer Cell, Journal Year: 2023, Volume and Issue: 41(3), P. 404 - 420

Published: Feb. 16, 2023

Language: Английский

Citations

198

Cancer vaccines: Building a bridge over troubled waters DOI Creative Commons

MacLean C. Sellars,

Catherine J. Wu, Edward F. Fritsch

et al.

Cell, Journal Year: 2022, Volume and Issue: 185(15), P. 2770 - 2788

Published: July 1, 2022

Language: Английский

Citations

191

Multiplexed 3D atlas of state transitions and immune interaction in colorectal cancer DOI Creative Commons
Jia‐Ren Lin, Shu Wang, Shannon Coy

et al.

Cell, Journal Year: 2023, Volume and Issue: 186(2), P. 363 - 381.e19

Published: Jan. 1, 2023

Advanced solid cancers are complex assemblies of tumor, immune, and stromal cells characterized by high intratumoral variation. We use highly multiplexed tissue imaging, 3D reconstruction, spatial statistics, machine learning to identify cell types states underlying morphological features known diagnostic prognostic significance in colorectal cancer. Quantitation these high-plex marker space reveals recurrent transitions from one tumor morphology the next, some which coincident with long-range gradients expression oncogenes epigenetic regulators. At invasive margin, where normal, immune compete, T suppression involves multiple imaging shows that seemingly localized 2D such as tertiary lymphoid structures commonly interconnected have graded molecular properties. Thus, while cancer genetics emphasizes importance discrete changes state, whole-specimen large-scale analogous those developing tissues.

Language: Английский

Citations

179

Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment DOI
Ayana T. Ruffin,

Housaiyin Li,

Lazar Vujanović

et al.

Nature reviews. Cancer, Journal Year: 2022, Volume and Issue: 23(3), P. 173 - 188

Published: Dec. 1, 2022

Language: Английский

Citations

160

Antibodies against endogenous retroviruses promote lung cancer immunotherapy DOI Creative Commons
Kevin W. Ng, Jesse Boumelha, Katey S.S. Enfield

et al.

Nature, Journal Year: 2023, Volume and Issue: 616(7957), P. 563 - 573

Published: April 12, 2023

Abstract B cells are frequently found in the margins of solid tumours as organized follicles ectopic lymphoid organs called tertiary structures (TLS) 1,2 . Although TLS have been to correlate with improved patient survival and response immune checkpoint blockade (ICB), underlying mechanisms this association remain elusive Here we investigate lung-resident cell responses patients from TRACERx 421 (Tracking Non-Small-Cell Lung Cancer Evolution Through Therapy) other lung cancer cohorts, a recently established immunogenic mouse model for adenocarcinoma 3 We find that both human adenocarcinomas elicit local germinal centre tumour-binding antibodies, further identify endogenous retrovirus (ERV) envelope glycoproteins dominant anti-tumour antibody target. ERV-targeting amplified by ICB humans mice, targeted inhibition KRAS(G12C) model. ERV-reactive antibodies exert activity extends model, ERV expression predicts outcome adenocarcinoma. Finally, effective immunotherapy requires CXCL13-dependent formation. Conversely, therapeutic CXCL13 treatment potentiates immunity synergizes ICB. Our findings provide possible mechanistic basis response.

Language: Английский

Citations

157

The roles of tertiary lymphoid structures in chronic diseases DOI Open Access
Yuki Sato, Karīna Siliņa, Maries van den Broek

et al.

Nature Reviews Nephrology, Journal Year: 2023, Volume and Issue: 19(8), P. 525 - 537

Published: April 12, 2023

Language: Английский

Citations

129

Spatial biology of cancer evolution DOI
Zaira Seferbekova, Artem Lomakin, Lucy Yates

et al.

Nature Reviews Genetics, Journal Year: 2022, Volume and Issue: 24(5), P. 295 - 313

Published: Dec. 9, 2022

Language: Английский

Citations

119